09:30 EST Capricor Therapeutics (CAPR) trading halted, volatility trading pause
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Capricor Therapeutics Announces Positive Phase 3 Trial Results
- Capricor Therapeutics says Phase 3 HOPE-3 study met primary endpoint
- Capricor presents data on framework for loading oligonucleotides into exosomes
- Largest borrow rate increases among liquid names
- Capricor Therapeutics’ HOPE-3 Trial: A Pivotal Catalyst for Future Success